Avacta Group Plc (AIM:AVCT)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 53.80
-1.80 (-3.24%)
Nov 6, 2026, 4:35 PM GMT
Avacta Group Market Cap
Avacta Group has a market cap or net worth of 261.89 million as of November 6, 2026. It is the 16,557th most valuable company in the world and the 362nd biggest in the United Kingdom. Its market cap has decreased by 15.96% in one year.
Market Cap
261.89M
Enterprise Value
261.48M
Revenue
113.00K
Global Rank
Country Rank
#362 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since September 29, 2006, Avacta Group's market cap has increased from 37.46M to 261.89M, an increase of 599.13%. That is a compound annual growth rate of 10.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 261.89M | 4.18% |
| Dec 31, 2025 | 251.39M | 37.41% |
| Dec 31, 2024 | 182.95M | -43.88% |
| Dec 29, 2023 | 325.99M | 9.26% |
| Dec 30, 2022 | 298.35M | -5.82% |
| Dec 31, 2021 | 316.78M | 11.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oxford Nanopore Technologies | 2.00B |
| Genus | 1.54B |
| Oxford Biomedica | 658.31M |
| PureTech Health | 293.73M |
| Bioventix | 101.47M |
| Scancell Holdings | 101.16M |
| 4basebio | 81.73M |
| Faron Pharmaceuticals Oy | 61.96M |